Danielle Bucco

Articles

Preoperative Imaging Remains Integral to Endometrial Cancer Diagnosis

January 15th 2018

Ingfrid Haldorsen, MD, discusses the role of imaging in the diagnosis of patients with endometrial cancer.

Global HPV Vaccination Reshaping Standard of Care for Cervical Cancer Prevention

January 15th 2018

Xavier Bosch, MD, discusses a second-generation vaccination against HPV for the prevention of cervical cancer.

Combinations Continue to Advance RCC Treatment

January 11th 2018

Rana R. McKay, MD, discusses the evolving management of patients with advanced RCC, specifically the future of combinations of with immunotherapy regimens.

Expert Highlights RESPONSE Results With Ruxolitinib in Polycythemia Vera

January 11th 2018

Ruben A. Mesa, MD, discusses the significance of the RESPONSE study for patients with polycythemia vera.

Efforts Continue to Optimize Immunotherapy in Gastric Cancer

January 10th 2018

David H. Ilson, MD, PhD, discusses practice-changing trials, the optimal available therapies, and how immunotherapy fits into the future treatment paradigm for gastric cancer.

Novel Approaches May Push Pancreatic Cancer Treatment Forward

January 9th 2018

Eileen O’Reilly, MD, discusses novel therapeutic approaches for the treatment of patients with pancreatic cancer.

Novel Treatments Emerging in HER2+ Breast Cancer Pipeline

January 8th 2018

Aleix Prat, MD, PhD, discusses the novel treatments being developed in the paradigm of HER2-positive breast cancer.

Combination Therapies Poised to Improve CLL Treatment Landscape

January 8th 2018

Aaron Logan, MD, PhD, discusses the most promising combinations and available treatments for patients with chronic lymphocytic leukemia.

Liver-Directed Therapy Shows Improvement in mCRC

January 5th 2018

Nancy E. Kemeny, MD, discusses the combination of pump and systemic therapy as a liver-directed treatment option for patients with metastatic colorectal cancer.

Developments With Gastrointestinal NETs Continue to Grow

January 5th 2018

Diane Reidy-Lagunes, MD, discusses ongoing developments for the treatment of patients with gastrointestinal and pancreatic NETs.

Pertuzumab and Other Agents Continue Progress in HER2+ Breast Cancer

January 2nd 2018

Adam M. Brufsky, MD, PhD, discusses the developing role of pertuzumab in HER2-positive breast cancer, as well as the impact of other agents in the field.

Precision Medicine Advancing GI Malignancies Field

January 2nd 2018

Luis A. Diaz, MD, discusses the precision medicine approaches available and in development for the treatment of patients with GI malignancies.

Liquid Biopsies a Quicker Alternative to Standard Approaches in NSCLC

January 1st 2018

Jared Weiss, MD, discusses utilizing liquid biopsies for patients with lung cancer, the pros and cons of the approach, and when it might be appropriate to rebiopsy patients.

Biomarker Testing Continues to Develop in NSCLC

December 28th 2017

Kathryn F. Mileham, MD, discusses the development of biomarker testing for patients with mutated non-small cell lung cancer.

Various Immunotherapy Combinations Continue to Be Explored in NSCLC

December 28th 2017

Daniel E. Haggstrom, MD, discusses the developing area of immunotherapy combinations for patients with non-small cell lung cancer.

Hamilton Highlights Treatment Landscape of HER2+ Breast Cancer

December 28th 2017

Erika P. Hamilton, MD, discusses recent FDA approvals in the treatment paradigm of HER2-positive breast cancer.

Molecular Testing Advancements Leading Field of GI Cancers

December 26th 2017

Shirley Michelle Shiller, DO, discusses progress with precision medicine for patients with gastrointestinal cancers.

Role of PARP Inhibitors Developing in mCRPC

December 26th 2017

Alicia Morgan, MD, discusses the role of PARP inhibitors as a novel treatment strategy for patients with metastatic castration-resistant prostate cancer.

Future of Bladder Cancer Likely to Be Combination Immunotherapy

December 21st 2017

Arjun Balar, MD, discusses novel immunotherapy combinations for the treatment of patients with bladder cancer.

Evolving Role of Surgery in Multidisciplinary Care for Head and Neck Cancer

December 18th 2017

Joseph A. Califano, MD, discusses how surgery factors into modern multidisciplinary care for patients with head and neck cancer.